Human Reproduction, Vol. 10, No. 10, pp. 2584-2589, 1995
© 1995 European Society of Human Reproduction and Embryology
research-article |
Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant®)
1Prince Henry's Institute of Medical Research PO Box 5152 2Department of Obstetrics and Gynaecology, Monash University 3Department of Pathology, Monash Medical Centre 246 Clayton Road, Clayton, Victoria 3168,Australia 4Human Reproduction Study Group, Department of Obstetrics and Gynaecology, University of Indonesia Klinik Raden Saleh, Jalan Raden Saleh 49,Jakarta 10330, Indonesia
Correspondence: 5To whom correspondence should be addressed
Subdermally implanted slow-release levonorgestrel (Norplant®), a widely used effective contraceptive, has a high rate of discontinuation due to unacceptable menstrual bleeding disturbances. Endothelin (ET), a potent vasoconstrictor,varies across the menstrual cycle in normal endometrium.It has been proposed that ET has a potential paracrine role in the regulation of uterine blood flow.Neutral endopeptidase (NEP), a membrane-bound ectoenzyme,can inactivate ET and is localized principally in endometrial stroma. We have compared the immunolocalization of ET and NEP in endometrial biopsies from Indonesian women using Norplant® with normal controls.Differences were observed in the glandular and luminal epithelium of Norplant®-treated subjects, where ET immunostaining was low while NEP immunoreactivity was increased. The latter may represent a local increase in enzyme activity, potentially explaining the reduced ET immunoreactivity. There was no correlation of ET immunoreactivity with the duration of implant use or total number of bleeding days. The marked differences in the ET immunostaining pattern in Norplant® users, with their increased risk of abnormal uterine bleeding, suggest that ET may be important in controlling menstrual bleeding.Whether endometrial epithelial cell ET has a role as a mitogen in endometrial repair and regeneration, or as a vasoconstrictor important in the cessation of bleeding following menstruation, remains to be determined.
Key words: endometrial bleeding/endothelin/neutral endopeptidase/Norplant®/slow-release levonorgestrel
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. B Morison, J. Zhang, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women Reproduction, January 1, 2007; 133(1): 309 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Jones, N. B. Morison, N. J. Hannan, H. O.D. Critchley, and L. A. Salamonsen Chemokine expression is dysregulated in the endometrium of women using progestin-only contraceptives and correlates to elevated recruitment of distinct leukocyte populations Hum. Reprod., October 1, 2005; 20(10): 2724 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding? Hum. Reprod., May 1, 2002; 17(5): 1189 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Galant, M. Vekemans, P. Lemoine, I. Kokorine, P. Twagirayezu, P. Henriet, C. Picquet, V. Rigot, Y. Eeckhout, P. J. Courtoy, et al. Temporal and Spatial Association of Matrix Metalloproteinases with Focal Endometrial Breakdown and Bleeding upon Progestin-Only Contraception J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4827 - 4834. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hickey, D. Dwarte, and I.S. Fraser Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding Hum. Reprod., July 1, 2000; 15(7): 1509 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, J. Zhang, A. Ostor, P.A.W. Rogers, B. Affandi, G. Kovacs, and L.A. Salamonsen Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives Hum. Reprod., January 1, 2000; 15(1): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.L. Hampton, G. Nie, and L.A. Salamonsen Progesterone analogues similarly modulate endometrial matrix metalloproteinase-1 and matrix metalloproteinase-3 and their inhibitor in a model for long-term contraceptive effects Mol. Hum. Reprod., April 1, 1999; 5(4): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Skinner, S. C. Riley, A. E. Gebbie, A. F. Glasier, and H. O.D. Critchley Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel Hum. Reprod., March 1, 1999; 14(3): 793 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.J. Vincent, N. Malakooti, J. Zhang, P.A.W. Rogers, B. Affandi, and L.A. Salamonsen Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B) Hum. Reprod., March 1, 1999; 14(3): 807 - 815. [Abstract] [Full Text] [PDF]
|
|